Editorial:: Phenotypic consequences of the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism:: The weight of the evidence in genetic association studies

被引：8

作者：

Florez, JC

机构：

[1] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[3] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA

[4] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02141 USA

[5] MIT, Cambridge, MA 02141 USA

[6] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2004年 / 89卷 / 09期

关键词：

D O I：

10.1210/jc.2004-1402

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4234 / 4237

页数：4

共 20 条

[11] Peroxisome proliferator-activated receptor γ:: Implications for cardiovascular disease [J].

Hsueh, WA ;

Bruemmer, D .

HYPERTENSION, 2004, 43 (02) :297-305

[12] Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease [J].

Lohmueller, KE ;

Pearce, CL ;

Pike, M ;

Lander, ES ;

Hirschhorn, JN .

NATURE GENETICS, 2003, 33 (02) :177-182

[13] Effect of the peroxisome proliferator activated receptor-γ gene Pro12Ala variant on body mass index:: a metaanalysis [J].

Masud, S ;

Ye, S .

JOURNAL OF MEDICAL GENETICS, 2003, 40 (10) :773-780

[14] The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes [J].

Nielsen, EMD ;

Hansen, L ;

Carstensen, B ;

Echwald, SM ;

Drivsholm, T ;

Glümer, C ;

Thorsteinsson, B ;

Borch-Johnsen, K ;

Hansen, T ;

Pedersen, O .

DIABETES, 2003, 52 (02) :573-577

[15] Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction [J].

Ridker, PM ;

Cook, NR ;

Cheng, S ;

Erlich, HA ;

Lindpaintner, K ;

Plutzky, J ;

Zee, RYL .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) :859-863

[16] Are variants in the CAPN10 gene related to risk of type 2 diabetes?: A quantitative assessment of population and family-based association studies [J].

Song, YQ ;

Niu, TH ;

Manson, JAE ;

Kwiatkowski, DJ ;

Liu, SM .

AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (02) :208-222

[17] PPAR-γ:: Adipogenic regulator and thiazolidinedione receptor [J].

Spiegelman, BM .

DIABETES, 1998, 47 (04) :507-514

[18] Ala12Ala genotype of the peroxisome proliferator-activated receptor γ2 protects against atherosclerosis [J].

Temelkova-Kurktschiev, T ;

Hanefeld, M ;

Chinetti, G ;

Zawadzki, C ;

Haulon, S ;

Kubaszek, A ;

Koehler, C ;

Leonhardt, W ;

Staels, B ;

Laakso, M .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4238-4242

[19] Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility [J].

Weedon, MN ;

Schwarz, PEH ;

Horikawa, Y ;

Iwasaki, N ;

Illig, T ;

Holle, R ;

Rathmann, W ;

Selisko, T ;

Schulze, J ;

Owen, KR ;

Evans, J ;

Bosque-Plata, LD ;

Hitman, G ;

Walker, M ;

Levy, JC ;

Sampson, M ;

Bell, GI ;

McCarthy, MI ;

Hattersley, AT ;

Frayling, TM .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) :1208-1212

[20] Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians:: Identification of a Pro12Ala PPARγ2 missense mutation [J].

Yen, CJ ;

Beamer, BA ;

Negri, C ;

Silver, K ;

Brown, KA ;

Yarnall, DP ;

Burns, DK ;

Roth, J ;

Shuldiner, AR .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (02) :270-274

← 1 2 →